{"id":"W2950864878","doi":"10.1200/jco.2013.31.15_suppl.6022","title":"A phase II study of dasatanib (BMS 354825) in recurrent or metastatic <i>ckit</i>-expressing adenoid cystic (ACC) and non-ACC malignant salivary glands tumors (MSGT).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Adverse effect; Dasatinib; Internal medicine; Gastroenterology; Nausea; Progressive disease; Response Evaluation Criteria in Solid Tumors; Vomiting; Stage (stratigraphy); Chemotherapy; Surgery; Imatinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001197687,0.001419467,0.002154264,0.000354101,0.0003770631,0.0009544161,0.0007736341,0.001095167,0.00329594],"category_scores_gemma":[0.0007156804,0.0006290421,0.000919431,0.000408922,0.0008082299,0.0008418827,0.0003195544,0.002327357,0.001014331],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006849683,"about_ca_system_score_gemma":0.001424829,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007987493,"about_ca_topic_score_gemma":0.002227483,"domain_scores_codex":[0.9996312,0.0001600033,0.00002143525,0.00007236252,0.00003383422,0.00008119582],"domain_scores_gemma":[0.9994292,0.00006797585,0.00008926815,0.00004636222,0.00003822825,0.0003289328],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6496326,0.1374632,0.01233145,0.001520511,0.001661301,0.0006636809,0.0006489541,0.002582525,0.08630227,0.0005433524,0.005360621,0.1012896],"study_design_scores_gemma":[0.4957745,0.4849011,0.0115643,0.00002661686,0.0003442241,0.0005009559,0.0001022646,0.001026606,0.003032907,0.0002142439,0.002484462,0.00002795292],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920603,0.001827099,0.000461811,0.0003634062,0.0001201491,0.003090604,0.0007543144,0.00006307373,0.001259249],"genre_scores_gemma":[0.9878405,0.002020774,0.001247152,0.0007691074,0.0001610922,0.003395222,0.001908803,0.00002353345,0.002633801],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00329594,"threshold_uncertainty_score":0.01102597,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1292075495369981,"score_gpt":0.4666290240801813,"score_spread":0.3374214745431832,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}